ACIPHEX® (rabeprazole sodium) Approved For Treatment Of Symptomatic Gastroesophageal Reflux Disease (GERD)
Proton Pump Inhibitor (PPI) Approved for Daytime and Nighttime Heartburn Relief
18-Feb-2002
Most read news
Topics
Proton
clinical trials
sodium
gastroesophageal reflux disease
Eisai
Warfarin
United Kingdom
reductions
pain
Northwestern University
Japan
Janssen Pharmaceutica
food
Evanston Northwestern Healthcare
endoscopy
dosing
diarrhea
acids
Other news from the department research and development
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.